 NEW YORK, Dec. 07, 2020 GLOBE NEWSWIRE -- Pomerantz LLP announces that a class action lawsuit has been filed against Zosano Pharma Corporation Zosano or the Company NASDAQ: ZSAN and certain of its officers. The class action, filed in United States District Court for the Northern District of California, and docketed under 20-cv-07850, is on behalf of a class consisting of all persons other than Defendants who purchased or otherwise acquired Zosano securities between February 13, 2017 and September 30, 2020, inclusive the Class Period, seeking to pursue claims against the Defendants under the Securities Exchange Act of 1934 the Exchange Act. 